The Design and Feasibility of Optimal Treatment for Coronary Drug-Eluting Stent In-Stent Restenosis (OPEN-ISR)—A Prospective, Randomised, Multicentre Clinical Trial
Introduction: Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) is a cornerstone of the management of ischemic heart disease. However, in-stent restenosis (ISR) remains a significant clinical challenge, occurring in approximately 5–10% of patients undergoing PCI. This study is...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2025
|
| Sorozat: | JOURNAL OF PERSONALIZED MEDICINE
15 No. 2 |
| Tárgyszavak: | |
| doi: | 10.3390/jpm15020060 |
| mtmt: | 35739269 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/35941 |